{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:14:14Z","timestamp":1772712854145,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.carrev.2024.12.001","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T11:59:20Z","timestamp":1733918360000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term outcomes of unselected patients undergoing coronary angiography according to the presence or absence of type II diabetes mellitus"],"prefix":"10.1016","volume":"78","author":[{"given":"Philipp","family":"Steinke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abumayyaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambis","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Ayasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Jannesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"D\u00fcrschmied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.carrev.2024.12.001_bb0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/dc19-1902","article-title":"Coronary artery disease and type 2 diabetes: A proteomic study","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01850-3","article-title":"The impact of diabetes on the relationship of coronary artery disease and outcome: a study using multimodality imaging","volume":"22","author":"M\u00e4enp\u00e4\u00e4","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.carrev.2024.12.001_bb0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.2.2.120","article-title":"Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study","volume":"2","author":"Kannel","year":"1979","journal-title":"Diabetes Care"},{"issue":"9733","key":"10.1016\/j.carrev.2024.12.001_bb0020","first-page":"2215","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"374","author":"SN, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J.","year":"2010","journal-title":"Lancet"},{"issue":"10397","key":"10.1016\/j.carrev.2024.12.001_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","author":"Collaborators","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2024.12.001_bb0030","unstructured":"Federation Id. Diabetes around the world in 2021 2021 [Available from: https:\/\/diabetesatlas.org\/."},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.carrev.2024.12.001_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/CLEP.S200173","article-title":"Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus<\/p>","volume":"11","author":"Gyldenkerne","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.carrev.2024.12.001_bb0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Emerging risk factors collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death.","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.carrev.2024.12.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"Bmj"},{"issue":"8","key":"10.1016\/j.carrev.2024.12.001_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cardfail.2019.05.007","article-title":"Type 2 diabetes mellitus and heart failure, A scientific statement from the American Heart Association and Heart Failure Society of America","volume":"25","author":"Dunlay","year":"2019","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12933-018-0768-y","article-title":"Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias","volume":"17","author":"Weidner","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.carrev.2024.12.001_bb0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1253\/circj.CJ-19-0980","article-title":"Diabetes mellitus and long-term risk for heart failure after coronary revascularization","volume":"84","author":"Takeji","year":"2020","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.carrev.2024.12.001_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1253\/circj.CJ-20-0015","article-title":"Major influence of diabetes on hospitalization for heart failure in patients with ischemic heart diseases","volume":"84","author":"Nagoshi","year":"2020","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.carrev.2024.12.001_bb0075","doi-asserted-by":"crossref","first-page":"16812","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.carrev.2024.12.001_bb0080","unstructured":"Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright \u00a9 2023, StatPearls Publishing LLC.; 2023."},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus \u2013 A hypercoagulable state","volume":"15","author":"Carr","year":"2000","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.carrev.2024.12.001_bb0090","first-page":"565","article-title":"The genetic link between diabetes and atherosclerosis","volume":"34","author":"Stephanie Ross","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.carrev.2024.12.001_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","article-title":"New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.","volume":"20","author":"Yuan","year":"2019","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.carrev.2024.12.001_bb0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4093\/dmj.2020.0282","article-title":"Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"issue":"38","key":"10.1016\/j.carrev.2024.12.001_bb0105","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.12.001_bb0110","unstructured":"WHO. Diagnosis and management of type 2 diabetes (HEARTS-D). Geneva2020. p. 35."},{"issue":"Supplement 1","key":"10.1016\/j.carrev.2024.12.001_bb0115","article-title":"Diabetes mellitus in coronary artery disease","volume":"29","author":"Diakonikolaou","year":"2022","journal-title":"European J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2024.12.001_bb0120","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.88.6.2510","article-title":"Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"88","author":"Johnstone","year":"1993","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2024.12.001_bb0125","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI119636","article-title":"Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation","volume":"100","author":"Steinberg","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.carrev.2024.12.001_bb0130","doi-asserted-by":"crossref","first-page":"H1480","DOI":"10.1152\/ajpheart.2001.280.4.H1480","article-title":"Platelet hyperactivity and abnormal ca(2+) homeostasis in diabetes mellitus","volume":"280","author":"Li","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.carrev.2024.12.001_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0140","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2020.17","article-title":"Mortality and morbidity in HFrEF, HFmrEF, and HFpEF patients with diabetes in the Middle East","volume":"35","author":"Al-Jarallah","year":"2020","journal-title":"Oman Med J"},{"issue":"23","key":"10.1016\/j.carrev.2024.12.001_bb0145","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese diastolic heart failure study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1016\/j.carrev.2024.12.001_bb0155","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl L","key":"10.1016\/j.carrev.2024.12.001_bb0160","doi-asserted-by":"crossref","first-page":"L124","DOI":"10.1093\/eurheartj\/suaa151","article-title":"Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction","volume":"22","author":"Gori","year":"2020","journal-title":"Eur Heart J Suppl"},{"issue":"8","key":"10.1016\/j.carrev.2024.12.001_bb0165","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.carrev.2024.12.001_bb0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.carrev.2024.12.001_bb0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/eurjhf\/hfs153","article-title":"Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial","volume":"15","author":"Sarma","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.carrev.2024.12.001_bb0180","doi-asserted-by":"crossref","unstructured":"Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, et al. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016;9(1).","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560"},{"issue":"2","key":"10.1016\/j.carrev.2024.12.001_bb0185","doi-asserted-by":"crossref","DOI":"10.1177\/14791641231224241","article-title":"Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: time to rethink pathophysiological models of disease progression","volume":"21","author":"Gierula","year":"2024","journal-title":"Diab Vasc Dis Res"},{"issue":"16","key":"10.1016\/j.carrev.2024.12.001_bb0190","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.carrev.2024.12.001_bb0195","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0735-1097(03)00856-8","article-title":"The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2024.12.001_bb0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9149(97)89163-1","article-title":"Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry","volume":"77","author":"Shindler","year":"1996","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2024.12.001_bb0205","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the heart failure Association of the European Society of cardiology","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.carrev.2024.12.001_bb0210","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.carrev.2024.12.001_bb0215","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2024.12.001_bb0220","first-page":"21","article-title":"Diabetes and heart failure","volume":"3","author":"Rhee","year":"2021","journal-title":"J Korean Diabetes"},{"issue":"1","key":"10.1016\/j.carrev.2024.12.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101265","article-title":"Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease","volume":"48","author":"Lemesle","year":"2022","journal-title":"Diabetes Metab"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T23:31:58Z","timestamp":1757115118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924007462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"alternative-id":["S1553838924007462"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.12.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of unselected patients undergoing coronary angiography according to the presence or absence of type II diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}